1783.TW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 06:00):

Stats
Dzisiejszy wolumen	22 374.00
Średni wolumen	144 329
Kapitalizacja rynkowa	3.75B
EPS	TWD0.460 ( 2023-11-08 )
Last Dividend	TWD0 ( N/A )
Next Dividend	TWD0 ( N/A )
P/E	22.81
ATR14	TWD0.0480 (0.11%)

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: 0.94 (very strong)

Signal:(44.912) Expect same movement, but be aware

Maxigen Biotech Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Maxigen Biotech Inc. Korelacja - Waluta/Towar

0.64
( weak )

0.57
( weak )

0.70
( moderate )

0.15
( neutral )

-0.29
( neutral )

-0.53
( weak negative )

Maxigen Biotech Inc. Finanse

Annual	2023
Przychody:	TWD622.12M
Zysk brutto:	TWD424.09M (68.17 %)
EPS:	TWD1.860

FY	2023
Przychody:	TWD622.12M
Zysk brutto:	TWD424.09M (68.17 %)
EPS:	TWD1.860

FY	2022
Przychody:	TWD604.43M
Zysk brutto:	TWD373.99M (61.88 %)
EPS:	TWD1.570

FY	2021
Przychody:	TWD511.98M
Zysk brutto:	TWD261.03M (50.98 %)
EPS:	TWD1.095

Financial Reports:

No articles found.

Maxigen Biotech Inc.

Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and skincare products in Taiwan and internationally. The company offers Formagraft, a bone graft substitute; Formasetin, a bone void filler; and intra-articular injections under the ArtiAid, ArtiAid Plus, and ArtiBest names for use in orthopedic area. It also provides Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental grafts for use in orthopedic and dental areas. In addition, the company offers FormaAid, a collagen membrane; and E-TECH DENTISTAR II sterilizer and disinfectant for use in dental area, as well as HealiAid, a collagen wound dressing product for use in dental and wound dressing area. Further, it provides ophthalmic viscoelastic device under the ViscAid, PreviscAid, and BiVisc names; and Formaderm, a dermal filler injection for use in plastic surgery. Additionally, the company offers skincare products, including face, neck, body, limbs, and other masks; and make up remover, cleansing, exfoliating, toner, essence, men's care, sunscreen, body care, hand/foot care, and special care products. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan City, Taiwan.